Skip to main content

Iopromide Injection Shortage

Last Updated: August 12, 2024
Status: Current

Products Affected - Description
    • Ultravist injection, Bayer, 240 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0342-10 - discontinued
    • Ultravist injection, Bayer, 300 mg iodine/ mL, 125 mL vial, 1 count, NDC 50419-0344-12 - discontinued
    • Ultravist injection, Bayer, 370 mg iodine/ mL, 200 mL vial, 1 count, NDC 50419-0346-20 - discontinued
Reason for the Shortage
    • Bayer has Ultravist products readily available. Bayer discontinued Ultravist 300 mg in 125 mL vials and 370 mg in 200 mL vials.
Available Products
    • Ultravist injection, Bayer, 300 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0344-10
    • Ultravist injection, Bayer, 300 mg iodine/ mL, 150 mL vial, 1 count, NDC 50419-0344-15
    • Ultravist injection, Bayer, 300 mg iodine/ mL, 50 mL vial, 1 count, NDC 50419-0344-05
    • Ultravist injection, Bayer, 370 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0346-10
    • Ultravist injection, Bayer, 370 mg iodine/ mL, 150 mL vial, 1 count, NDC 50419-0346-15
    • Ultravist injection, Bayer, 370 mg iodine/ mL, 50 mL vial, 1 count, NDC 50419-0346-05

Updated

Updated August 12, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created June 24, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer